Prospects for immunotherapy in cervical cancer.
D000914:Antibodies, Viral / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000639:trends*; D027383:Papillomaviridae / Q000472:pathogenicity; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000628:therapy*
D000914:Antibodies, Viral